Skip to main content

Together we are beating cancer

Donate now

Diagnosing cancer

Showing 12 out of 800 results
Cancer Research UK logo
  • Science & Technology
  • Health & Medicine

Cancer genes differ in different parts of a tumour

Taking a sample from just one part of a tumour may not give a full picture of its 'genetic landscape', according to a landmark study published in the New England Journal of Medicine today (Wednesday). Taking a sample from just one part of a tumour may not give a full picture of its 'genetic landscape', according to a landmark study published in the New England Journal of Medicine today (Wednesday).

by Cancer Research UK | News | 7 March 2012

7 March 2012

Cancer Research UK logo

More than three quarters of people asked to list possible warning signs and symptoms of cancer failed to mention pain, coughing or problems with bowels or bladder according to a Cancer Research UK report, Delay Kills, funded by Tesco and published today (Tuesday March 6th). More than three quarters of people asked to list possible warning signs and symptoms of cancer failed to mention pain, coughing or problems with bowels or bladder according to a Cancer Research UK report, Delay Kills, funded by Tesco and published today (Tuesday March 6th).

by Cancer Research UK | News | 6 March 2012

6 March 2012

Cancer Research UK logo

Testing for the human papillomavirus (HPV) - a virus most women will encounter at some point in their lives - followed by a smear test if they are HPV positive, provides the most effective approach for cervical screening, new research shows today (Wednesday). Testing for the human papillomavirus (HPV) - a virus most women will encounter at some point in their lives - followed by a smear test if they are HPV positive, provides the most effective approach for cervical screening, new research shows today (Wednesday).

by British Journal of Cancer | News | 29 February 2012

29 February 2012

Cancer Research UK logo

Leading breast cancer experts are calling for women under 50 diagnosed with triple-negative breast cancer to be offered testing for faults in the BRCA1 gene. Leading breast cancer experts are calling for women under 50 diagnosed with triple-negative breast cancer to be offered testing for faults in the BRCA1 gene.

by Cancer Research UK | News | 15 February 2012

15 February 2012

Cancer Research UK logo

Cancer Research UK-funded scientists have determined that a magnetic resonance imaging (MRI) technique, which measures the movement of water molecules within the tumour, may be the best way to monitor how women with late-stage ovarian cancer are responding to treatment. The study is published in the journal Radiology today. Cancer Research UK-funded scientists have determined that a magnetic resonance imaging (MRI) technique, which measures the movement of water molecules within the tumour, may be the best way to monitor how women with late-stage ovarian cancer are responding to treatment. The study is published in the journal Radiology today.

by Cancer Research UK | News | 14 February 2012

14 February 2012

Cancer Research UK logo

Cancer Research Technology, the commercial arm of Cancer Research UK, has today launched Acublate Limited, a spin-out company which will develop a next-generation High Intensity Focused Ultrasound (HIFU) surgery device to treat a range of solid tumour types. Cancer Research Technology, the commercial arm of Cancer Research UK, has today launched Acublate Limited, a spin-out company which will develop a next-generation High Intensity Focused Ultrasound (HIFU) surgery device to treat a range of solid tumour types.

by Cancer Research Technology (CRT) | News | 26 January 2012

26 January 2012